Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
, 13 (4), 333-45

Epidemiology of Headache in Europe

Affiliations
Review

Epidemiology of Headache in Europe

L J Stovner et al. Eur J Neurol.

Abstract

The present review of epidemiologic studies on migraine and headache in Europe is part of a larger initiative by the European Brain Council to estimate the costs incurred because of brain disorders. Summarizing the data on 1-year prevalence, the proportion of adults in Europe reporting headache was 51%, migraine 14%, and 'chronic headache' (i.e. > or =15 days/month or 'daily') 4%. Generally, migraine, and to a lesser degree headache, are most prevalent during the most productive years of adulthood, from age 20 to 50 years. Several European studies document the negative influence of headache disorders on the quality of life, and health-economic studies indicate that 15% of adults were absent from work during the last year because of headache. Very few studies have been performed in Eastern Europe, and there are also surprisingly little data on tension-type headache from any country. Although the methodology and the quality of the published studies vary considerably, making direct comparisons between different countries difficult, the present review clearly demonstrates that headache disorders are extremely prevalent and have a vast impact on public health. The data collected should be used as arguments to increase resources to headache research and care for headache patients all over the continent.

Similar articles

  • Cost of disorders of the brain in Europe 2010.
    Gustavsson A, Svensson M, Jacobi F, Allgulander C, Alonso J, Beghi E, Dodel R, Ekman M, Faravelli C, Fratiglioni L, Gannon B, Jones DH, Jennum P, Jordanova A, Jönsson L, Karampampa K, Knapp M, Kobelt G, Kurth T, Lieb R, Linde M, Ljungcrantz C, Maercker A, Melin B, Moscarelli M, Musayev A, Norwood F, Preisig M, Pugliatti M, Rehm J, Salvador-Carulla L, Schlehofer B, Simon R, Steinhausen HC, Stovner LJ, Vallat JM, Van den Bergh P, van Os J, Vos P, Xu W, Wittchen HU, Jönsson B, Olesen J; CDBE2010Study Group. Gustavsson A, et al. Eur Neuropsychopharmacol. 2011 Oct;21(10):718-79. doi: 10.1016/j.euroneuro.2011.08.008. Epub 2011 Sep 15. Eur Neuropsychopharmacol. 2011. PMID: 21924589
  • The cost of headache disorders in Europe: the Eurolight project.
    Linde M, Gustavsson A, Stovner LJ, Steiner TJ, Barré J, Katsarava Z, Lainez JM, Lampl C, Lantéri-Minet M, Rastenyte D, Ruiz de la Torre E, Tassorelli C, Andrée C. Linde M, et al. Eur J Neurol. 2012 May;19(5):703-11. doi: 10.1111/j.1468-1331.2011.03612.x. Epub 2011 Dec 5. Eur J Neurol. 2012. PMID: 22136117
  • Headache-attributed burden and its impact on productivity and quality of life in Russia: structured healthcare for headache is urgently needed.
    Ayzenberg I, Katsarava Z, Sborowski A, Chernysh M, Osipova V, Tabeeva G, Steiner TJ. Ayzenberg I, et al. Eur J Neurol. 2014 May;21(5):758-65. doi: 10.1111/ene.12380. Epub 2014 Feb 13. Eur J Neurol. 2014. PMID: 24520863
  • Impact of headache in Europe: a review for the Eurolight project.
    Stovner LJ, Andrée C; Eurolight Steering Committee. Stovner LJ, et al. Version 2. J Headache Pain. 2008 Jun;9(3):139-46. doi: 10.1007/s10194-008-0038-6. Epub 2008 Apr 17. J Headache Pain. 2008. PMID: 18418547 Free PMC article. Review.
  • Prevalence, burden, and cost of headache disorders.
    Stovner LJ, Hagen K. Stovner LJ, et al. Curr Opin Neurol. 2006 Jun;19(3):281-5. doi: 10.1097/01.wco.0000227039.16071.92. Curr Opin Neurol. 2006. PMID: 16702836 Review.
See all similar articles

Cited by 95 articles

See all "Cited by" articles

LinkOut - more resources

Feedback